Patents by Inventor Doo Hyun CHUNG

Doo Hyun CHUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient
    Patent number: 12091465
    Abstract: The present invention relates to a composition for preventing or treating diseases caused by overexpression of chemokine CX3CL1 (fractalkine) comprising a death receptor 5 (DR5) inhibitor as an active ingredient, a method for preventing or treating diseases caused by overexpression of chemokine CX3CL1 comprising administering a DR5 expression or activity inhibitor to a patient in need of prevention or treatment of diseases caused by overexpression of chemokine CX3CL1 in a therapeutically effective amount, and a use for prevention or treatment of diseases caused by overexpression of chemokine CX3CL1 of a DR5 expression or activity inhibitor.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: September 17, 2024
    Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Doo Hyun Chung, Eugene C. Yi, Dongjin Jeong, Min Jueng Kang, Donghyun Kim
  • COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY OVEREXPRESSION OF CHEMOKINE CX3CL1, CONTAINING DEATH RECEPTOR INHIBITOR AS ACTIVE INGREDIENT
    Publication number: 20230159650
    Abstract: The present invention relates to a composition for preventing or treating diseases caused by overexpression of chemokine CX3CL1 (fractalkine) comprising a death receptor 5 (DR5) inhibitor as an active ingredient, a method for preventing or treating diseases caused by overexpression of chemokine CX3CL1 comprising administering a DR5 expression or activity inhibitor to a patient in need of prevention or treatment of diseases caused by overexpression of chemokine CX3CL1 in a therapeutically effective amount, and a use for prevention or treatment of diseases caused by overexpression of chemokine CX3CL1 of a DR5 expression or activity inhibitor.
    Type: Application
    Filed: August 14, 2018
    Publication date: May 25, 2023
    Inventors: Doo Hyun CHUNG, Eugene C. YI, Dongjin JEONG, Min Jueng KANG, Donghyun KIM
  • METHOD FOR SCREENING COMPOUNDS FOR TREATING SEPSIS TARGETING NOD2 SIGNALLING PATHWAY AND COMPOSITION FOR TREATING SEPSIS COMPRISING NOD2 SIGNALLING PATHWAY INHIBITORS
    Publication number: 20130251702
    Abstract: Methods for screening compounds for treating sepsis are disclosed. The present methods and compositions are targeting NOD2 mediated signaling pathway and the agents identified by the present methods are qualified as drug candidates for clinical development. Further Methods and composition for treating sepsis are disclosed.
    Type: Application
    Filed: March 21, 2013
    Publication date: September 26, 2013
    Applicant: SNU R&DB FOUNDATION
    Inventors: Doo Hyun CHUNG, Sae Jin OH, Ji Hyung KIM